Chart: Aptahem AB

Timeframe

Style

Latest news : Aptahem AB

06-17	Aptahem Improves Quality And Manufacturing Efficiency In A New Apta-1 Test Batch	CI
06-17	Aptahem Reports Improved Production of Apta-1	FW
05-28	Aptahem AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-28	Aptahem reports narrowed operating loss	FW
05-11	Aptahem to focus on conditions mirroring sepsis pathology - newsletter	FW
04-28	Aptahem finalizes rights issue results - subscribed to 23.7 percent	FW
04-24	Aptahem raises SEK 3.3 million in undersubscribed rights issue - preliminary figures	FW
04-07	Aptahem shares trade ex-rights on Spotlight today following rights issue	FW
03-27	Aptahem announces rights issue of approximately SEK 13.8 million	FW
02-26	Aptahem AB Auditor Raises 'Going Concern' Doubt	CI
02-25	Aptahem Proposes Election of Brian Packard to the Board	FW
02-12	Aptahem Reports Minor Changes in Results – Data Room Activity at Record High	FW
02-12	Aptahem AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

25-09-19

06-22	Aptahem: Newsletter June 2026	PU
06-22	Newsletter June 2026	AQ
06-17	Aptahem: Aptahem Improves Quality and Manufacturing Efficiency in a New Apta-1 Test Batch	PU
06-17	Aptahem Improves Quality and Manufacturing Efficiency in a New Apta-1 Test Batch	AQ
06-05	Aptahem: Aptahem to Participate at IOPC 2026 in Athens	PU

Manager	Title	Age	Since
Luiza Jedlina CTO	Chief Tech/Sci/R&D Officer	-	2016-02-29
Knut Mikael Ingolf Lindstam CEO	Chief Executive Officer	60	2013-12-31
Ola Skanung DFI	Director of Finance/CFO	62	-

Director	Title	Age	Since
Knut Mikael Ingolf Lindstam BRD	Director/Board Member	60	2013-12-31
Johan Lindh BRD	Director/Board Member	-	-
Ulla Cristina Glad BRD	Director/Board Member	74	2016-05-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
APTAHEM AB	-8.97%	-3.73%	-51.24%	-97.72%	1.69M
ARGENX SE	+2.87%	+4.57%	+68.97%	+119.22%	55.19B
WUXI APPTEC CO., LTD.	+4.00%	+7.14%	+63.67%	+68.77%	45.75B
BIONTECH SE	-0.77%	-0.67%	-15.34%	-15.95%	22.98B
INSMED INCORPORATED	+2.93%	+1.17%	-3.97%	+384.78%	20.76B
WUXI BIOLOGICS (CAYMAN) INC.	-0.26%	-0.58%	+27.55%	-18.57%	16.26B
GENMAB A/S	+1.16%	+3.86%	+20.23%	-36.42%	15.42B
EXELIXIS, INC.	-1.08%	-3.11%	+27.20%	+158.30%	13.05B
PHARMAESSENTIA CORPORATION	+3.30%	+15.02%	+133.24%	+273.89%	12.45B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-5.63%	-6.39%	+21.79%	-	12.37B
Average	-0.25%	+2.95%	+29.21%	+92.92%	21.42B
Weighted average by Cap.	+1.66%	+3.92%	+43.54%	+108.79%